Contribution of endogenous generation of endothelin-1 to basal vascular tone
References (16)
- et al.
Phosphoramidon inhibits the generation of endothelin-1 from exogenously applied big endothelin-1 in cultured vascular endothelial cells and smooth muscle cells
FEBS Letters
(1991) - et al.
Endothelins come of age
Lancet
(1993) - et al.
Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor
Life Sci
(1992) - et al.
Regional vasodilation to endothelin-1 is mediated by a non-ETA receptor subtype in the anaethetised rat: effect of BQ-123 on systemic haemodynamic responses
Eur J Pharmacol
(1992) - et al.
Antihypertensive effect of a newly synthetised endothelin antagonist, BQ-123, in a genetic hypertensive model
Life Sci
(1993) - et al.
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Nature
(1988) - et al.
Phosphoramidon blocks the pressor activity of big endothelin [1-39] and lowers blood pressure in spontaneously hypertensive rats
J Cardiovasc Pharmacol
(1991)
There are more references available in the full text version of this article.
Cited by (550)
New Dual Endothelin Receptor Antagonist Aprocitentan in Hypertension: A Systematic Review and Meta-Analysis
2023, Current Problems in CardiologyArterial stiffness, endothelial dysfunction and impaired fibrinolysis are pathogenic mechanisms contributing to cardiovascular risk in ANCA-associated vasculitis
2022, Kidney InternationalCitation Excerpt :The presence of compensatory endothelial NO generation pathways that contribute to tPA release in health32 may explain these contrasting results. Our findings in AAV likely reflect the combined effects of ET-1–mediated inhibition of endothelial NO generation33–35 and enhanced monocyte adhesion due to impaired ETB function, both of which contribute to regulation of endogenous fibrinolysis.32,36 In addition, at baseline, tPA activity was lower in AAV than in health, and this might be explained, in part, by the higher plasma concentration of PAI-1, the endogenous inhibitor of tPA, in AAV.
Cardiovascular effects of prenatal stress—Are there implications for cerebrovascular, cognitive and mental health outcome?
2020, Neuroscience and Biobehavioral Reviews
Copyright © 1994 Published by Elsevier Ltd.